Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA regorafenib CTRPv2 pan-cancer AAC -0.085 0.04
mRNA neopeltolide CTRPv2 pan-cancer AAC -0.16 0.04
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.069 0.04
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.081 0.04
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.093 0.04
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.04
mRNA manumycin A CTRPv2 pan-cancer AAC -0.07 0.04
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.04
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA SU11274 CTRPv2 pan-cancer AAC -0.077 0.04
Download CSV